Antibody Gene Gene Silencing Pharma Companies 
pharmaphorum
DECEMBER 23, 2020
The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade. Pharma companies have also made headway in rare diseases as several pipeline projects came to fruition. Rare disease progress.
Delveinsight
AUGUST 6, 2020
Hereditary ATTR amyloidosis , also known as Familial ATTR, is an autosomal dominant disease and a result of mutations in the TTR gene, thus it is passed down from one generation to the next one. Gene-silencing Therapies. ATTR amyloidosis can be either hereditary or acquired (non-hereditary). hATTR market : In The Pipeline.
Expert insights. Personalized for you.
96 
Let's personalize your content